Marc S. PENN,Rahul ARAS,Joseph PASTORE,Scott J. FISHER
申请号：
US14773984
公开号：
US20160024521A1
申请日:
2014.03.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are methods of treating a subject with a cardiomyopathy by administering to the subjects heart, via percutaneous retrograde coronary sinus perfusion, a pharmaceutical composition that comprises a DNA plasmid encoding SDF-1 and a pharmaceutically acceptable carrier or diluent.
